| |
| |
|
| Insider
Information: |
Parini Michael |
| Relationship: |
EVP, Chief Adm, Leg & ... |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
30,837 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$14,824,271 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
30,837 |
|
|
| Total
Value |
$14,824,271 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, Chief Adm, Leg & ... |
2021-02-25 |
30,837 |
2016-01-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
115 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2020-01-06 |
4 |
OE |
$122.45 |
$520,413 |
D/D |
4,250 |
39,253 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Adm, Leg & BD Off |
• – – |
2021-02-24 |
4 |
D |
$217.57 |
$525,649 |
D/D |
(2,416) |
33,865 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Adm, Leg & BD Off |
• – – |
2020-04-29 |
4 |
AS |
$251.38 |
$541,769 |
D/D |
(2,125) |
26,838 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Adm, Leg & BD Off |
• – – |
2021-02-10 |
4 |
D |
$214.16 |
$548,892 |
D/D |
(2,563) |
54,664 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-01-22 |
4 |
OE |
$155.57 |
$570,631 |
D/D |
3,668 |
43,277 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2020-02-24 |
4 |
D |
$239.23 |
$577,980 |
D/D |
(2,416) |
29,866 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-02-01 |
4 |
AS |
$174.11 |
$600,680 |
D/D |
(3,450) |
25,493 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2020-02-17 |
4 |
D |
$241.50 |
$602,784 |
D/D |
(2,496) |
35,410 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2020-02-06 |
4 |
AS |
$238.77 |
$604,783 |
D/D |
(2,526) |
68,246 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Adm, Leg & BD Off |
• – – |
2020-05-04 |
4 |
AS |
$259.19 |
$607,827 |
D/D |
(2,330) |
26,838 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Adm, Leg & BD Off |
• – – |
2020-07-13 |
4 |
AS |
$284.28 |
$620,610 |
D/D |
(2,125) |
26,838 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Adm, Leg & BD Off |
• – – |
2021-02-25 |
4 |
AS |
$211.58 |
$646,125 |
D/D |
(3,028) |
30,837 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Adm, Leg & BD Off |
• – – |
2020-08-03 |
4 |
AS |
$276.98 |
$648,402 |
D/D |
(2,330) |
26,838 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-02-01 |
4 |
AS |
$190.92 |
$658,674 |
D/D |
(3,450) |
36,159 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-01-04 |
4 |
AS |
$165.90 |
$705,075 |
D/D |
(4,250) |
39,609 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2020-02-25 |
4 |
AS |
$230.07 |
$707,005 |
D/D |
(3,028) |
26,838 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-04-16 |
4 |
OE |
$90.29 |
$712,279 |
D/D |
6,375 |
37,128 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-01-22 |
4 |
AS |
$195.00 |
$715,260 |
D/D |
(3,668) |
39,609 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-07-05 |
4 |
AS |
$168.38 |
$715,615 |
D/D |
(4,250) |
39,609 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2020-01-31 |
4 |
OE |
$187.53 |
$733,055 |
D/D |
3,909 |
38,912 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-10-17 |
4 |
AS |
$177.80 |
$755,650 |
D/D |
(4,250) |
35,003 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-07-05 |
4 |
AS |
$178.01 |
$761,239 |
D/D |
(4,250) |
35,003 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2020-02-18 |
4 |
AS |
$241.75 |
$762,020 |
D/D |
(3,128) |
32,282 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-10-04 |
4 |
AS |
$191.58 |
$814,215 |
D/D |
(4,250) |
39,609 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Adm, Leg & BD Off |
• – – |
2021-02-11 |
4 |
AS |
$210.43 |
$909,179 |
D/D |
(4,318) |
50,346 |
0 |
% |
|
115 Records found
|
|
Page 4 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
